WeightWatchers is getting into the booming prescription weight loss drug business.
The company, now known as WW International, will buy Sequence, a telehealth subscription service that connects patients with doctors who can prescribe weight-loss and diabetes drugs, including the hot new diabetes drug Ozempic. WeightWatchers offers subscribers meal plans and other tools to lose weight. Oprah Winfrey has a partnership with and stake in the company.
Shares of WW International \n \n surged 20% during pre-market trading Tuesday on the news. Although WeightWatchers didn’t specifically mention Ozempic or any other drug, the company noted that Sequence’s $99-a-month subscription plan helps connect customers to doctors who can prescribe drugs that mimic an appetite-regulating hormone called GLP-1. The GLP-1 agonists Sequence helps prescribe include Wegovy, Ozempic, and Rybelsus.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
WeightWatchers gets into prescription weight loss businessWith the acquisition of Sequence, the company is tapping into a red-hot market for prescription drugs that address obesity, and broadening what it offers to customers.
Read more »
CNN anchor Kasie Hunt gives birth in surprise 13-minute labor | CNN BusinessCNN anchor and chief national affairs analyst Kasie Hunt and husband Matthew Mario Rivera welcomed their second child to the world last week in an unforgettable way.
Read more »
Head of UK business lobby steps aside following complaints about his conduct | CNN BusinessThe head of the main business lobby in the United Kingdom is stepping aside while an investigation takes place into complaints about his workplace conduct.
Read more »
WSJ News Exclusive | WeightWatchers Moves Into the Ozempic Market With Telehealth DealThe weight-management company is buying digital health company Sequence, which offers telehealth visits with doctors.
Read more »
WeightWatchers Bets on So-Called Miracle Obesity Drug Ozempic in New Deal: ReportThe Wall Street Journal reported Monday that WeightWatchers is buying a telehealth subscription service called Sequence, which allows doctors to prescribe both Ozempic and its sister drug, Wegovy.
Read more »
WeightWatchers Buying Telehealth Service Known For Ozempic Weight Loss Prescriptions, Report SaysWW’s stock jumped more than 13% in after-hours trading following news of the deal Monday.
Read more »